Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterisation of five factor XI mutations.

Michael J Mitchell1, Letian Dai, John B Clarke

  • 1Centre for Haemostasis and Thrombosis, Haemophilia Reference Centre, 1st Floor North Wing, St. Thomas' Hospital, London SE1 7EH, United Kingdom. michael.mitchell@kcl.ac.uk

Thrombosis and Haemostasis
|June 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transient T cell therapies.

Advances in pharmacology (San Diego, Calif.)·2026
Same author

Influence of protein aggregates, extracellular vesicles, and lipoprotein fusion on ionizable lipid nanoparticles protein corona analysis.

Nature communications·2026
Same author

Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumors.

Bioengineering & translational medicine·2026
Same author

Reductive contact and dipolar interface engineering enable stable flexible CsSnI<sub>3</sub> nanowire photodetectors.

Nanoscale·2026
Same author

Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2026

Five factor XI (FXI) mutations were studied, with three preventing FXI secretion and two showing reduced activity. All five mutations are confirmed as causes of factor XI deficiency.

Area of Science:

  • Molecular Biology
  • Hematology
  • Genetics

Background:

  • Factor XI (FXI) deficiency is a bleeding disorder.
  • Identifying causative mutations is crucial for understanding FXI deficiency.
  • Previous studies have identified various FXI mutations and polymorphisms.

Purpose of the Study:

  • To investigate the functional consequences of five selected FXI missense mutations.
  • To confirm whether previously reported polymorphisms or mild mutations are indeed causative of FXI deficiency.

Main Methods:

  • Site-directed mutagenesis was used to recreate five FXI missense mutations in cDNA.
  • Mutant FXI was expressed in a BHK-570 cell line.
  • Secretion levels and Factor IX activation activity of mutant FXI were analyzed.

Related Experiment Videos

Main Results:

  • Three mutations (Met-18Ile, Met102Thr, Tyr133Ser) resulted in a non-secreted, cross-reactive material negative (CRM-) FXI.
  • Two mutations (Thr575Met, Arg378Cys) were secreted but exhibited negligible Factor IX activation activity.
  • The study confirmed all five mutations, including a previously reported polymorphism and a mild mutation, as causative of FXI deficiency.

Conclusions:

  • Missense mutations in FXI can lead to deficiency through impaired secretion or reduced enzymatic activity.
  • Genetic variations previously classified as polymorphisms or mild mutations can be causative of FXI deficiency.
  • This study validates the pathogenicity of five FXI missense mutations, contributing to a better understanding of FXI deficiency.